Major metabolites of (±)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons

Research output: Contribution to journalArticle


The two major metabolites of (±)3,4-methylenedioxyamphetamine (MDA), alpha-methyldopamine (α-MeDA) and 3-O-methyl-α-methyldopamine (3-O-Me-α-MeDA), were administered to rats intracerebroventricularly and into brain parenchyma. In addition, their precursors, (α-MeDOPA and 3-O-Me-α-MeDOPA, respectively) were administered systemically, individually and in combination. None of these treatments produced a lasting depletion of brain serotonin (5-HT). These findings suggest that neither of MDA's major metabolites mediate its toxic effects on 5-HT neurons and that either a minor metabolite is responsible or that alternate mechanisms are involved.

Original languageEnglish (US)
Pages (from-to)279-282
Number of pages4
JournalBrain Research
Issue number1-2
Publication statusPublished - Apr 5 1991



  • Amphetamine
  • Methylenedioxyamphetamine
  • Neurotoxicity
  • Serotonin
  • α-Methyl-DOPA

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this